androgen


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

an·dro·gen

 (ăn′drə-jən)
n.
A steroid hormone, such as testosterone or androsterone, that controls the development and maintenance of masculine characteristics. Also called androgenic hormone.

an′dro·gen′ic (-jĕn′ĭk) adj.

androgen

(ˈændrədʒən)
n
(Biochemistry) any of several steroids, produced as hormones by the testes or made synthetically, that promote development of male sexual organs and male secondary sexual characteristics
androgenic adj

an•dro•gen

(ˈæn drə dʒən, -ˌdʒɛn)

n.
any substance, as testosterone or androsterone, that promotes male characteristics.
[1935–40]
an`dro•gen′ic (-ˈdʒɛn ɪk) adj.

an·dro·gen

(ăn′drə-jən)
Any of several steroid hormones, such as testosterone, that control the development and maintenance of physical characteristics in males.

androgen

A natural steroid hormone, such as testosterone, that controls male sex characteristics.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.androgen - male sex hormone that is produced in the testes and responsible for typical male sexual characteristicsandrogen - male sex hormone that is produced in the testes and responsible for typical male sexual characteristics
sex hormone, steroid hormone, steroid - any hormone affecting the development and growth of sex organs
androsterone - an androgenic hormone that is less active than testosterone
methyltestosterone - an androgenic compound contained in drugs that are used to treat testosterone deficiency and female breast cancer and to stimulate growth and weight gain
Durabolin, Kabolin, nandrolone - an androgen (trade names Durabolin or Kabolin) that is used to treat testosterone deficiency or breast cancer or osteoporosis
testosterone - a potent androgenic hormone produced chiefly by the testes; responsible for the development of male secondary sex characteristics
Translations

androgen

[ˈændrədʒən] Nandrógeno m

androgen

nAndrogen nt

an·dro·gen

n. andrógeno, hormona masculina.

androgen

n andrógeno
References in periodicals archive ?
Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
Androgen, also called androgenic hormone or testoid, is the generic term for any natural or synthetic compound, usually a steroid hormone that stimulates or controls the development and maintenance of male characteristics in vertebrates by binding to androgen receptors.
ORLANDO -- Periodic breaks from androgen suppression therapy did not impact survival in men with prostate-specific antigen progression after radical therapy for prostate cancer.
In their recent comprehensive update on the molecular biology of prostate cancer, Mackinnon et al (1) refer to the interesting possibility that the significance of TMPRSS2 (transmembrane protease, serine 2) fusion genes, including the commonest type, TMPRSS2:ERG (v-ets erythroblastosis virus E26 oncogene homologue), now known to be present in at least 50% of cases, (2) may be quite different depending on the androgen receptor status of the tumor.
Insulin resistance appears to play a major role in a vicious cycle that alters female hormone metabolism towards androgen dominance.
CHICAGO -- Six or more months of continuous androgen deprivation therapy was associated with significantly increased risk of fragility fractures and type 2 diabetes in an observational study of nearly 20,000 men aged 66 years and older with prostate cancer, reported investigators at the annual meeting of the American Society of Clinical Oncology.
Excessive and deficient androgen levels have been linked to:
Although women produce only one tenth the amount of androgen that men do, testosterone and related androgen metabolites are as important to women throughout the lifespan as is estrogen.
Some girls have excessive weight gain, which is difficult to lose but, if it can be lost, androgen levels will drop and with them the amount of excessive hair.
RESULTS: We found activation of HER-2/neu oncogene in transformed CAsE-PE cells, providing molecular evidence of androgen independence in the transformed cells.
has been granted priority review designation by the US Food and Drug Administration for the new drug application for apalutamide, an investigational, next-generation oral androgen receptor inhibitor for the treatment of men with non-metastatic castration-resistant prostate cancer (CRPC).
According to the company, apalutamide is an investigational, next-generation oral androgen receptor inhibitor that inhibits the action of androgen in prostate cancer cells, and prevents binding of androgen to the androgen receptor, and translocation of the androgen receptor to the nucleus of the cancer cell.